CMI Awards Round-2 Early Stage Translational Research Seed Grants

The Center for Medical Innovation (CMI), in connection with the Department of Bioengineering, has made awards to three projects in its 2024 Round-2 Early Stage Translational Research Seed Grant competition. The purpose of these awards is to fund the development of innovative concepts in translational medicine, which were originated by teams of clinicians, SSOE engineers, and their students. The awards, totaling $47,000 are granted to the following project teams:

“One-Pass Epidural Needle”

Trent Emerick, MD, MBA & Kevin Bell, PhD

For development and testing of a novel device that allows for multiple spinal cord stimulator leads to be placed through one needle without the need of removal. 

“A Novel Controllable Intravesical Bladder Outlet Occlusion Device (CIBOD)”

Roger Klein, MD, PhD, Paul Rusilko, DO, & Youngjae Chun, PhD

For development and testing of a novel device that augments the leak point pressure of the bladder during pressure increases that are characteristic of stress urinary incontinence (SUI) and urge urinary incontinence (UUI).

“Chemically Informed Deep Brain Stimulation for Parkinson’s Disease”

Ritesh Shrivastav, Shreya Mahajan, Aaron Batista, PhD, Jorge González-Martínez, MD & Helen Schwerdt, PhD

For development and testing of a novel chemically informed deep brain stimulation in order to treat Parkinson’s Disease.